Market Indices
Sector Heatmap
CRVO — CervoMed Inc. Common Stock
NasdaqCervoMed Inc. Common Stock
- O
- 2.96
- H
- 3.07
- L
- 2.88
- V
- 211.29K
CRVO — Latest News & Headlines
8 StoriesCRVO Stock Rockets Nearly 100% On Patent Win Before Offering News Cools Rally - Stocktwits
CRVO Stock Rockets Nearly 100% On Patent Win Before Offering News Cools Rally Stocktwits
The new tablet had about 20% lower peaks and about 20% higher levels at 12 hours than the old capsule. - Stock Titan
The new tablet had about 20% lower peaks and about 20% higher levels at 12 hours than the old capsule. Stock Titan
Hopeful Week For Insiders Who Bought US$3.46m Of CervoMed Stock - Simply Wall Street
Hopeful Week For Insiders Who Bought US$3.46m Of CervoMed Stock Simply Wall Street
CervoMed (CRVO) Advances Neflamapimod Development with New 50 mg Tablet and FDA Update - gurufocus.com
CervoMed (CRVO) Advances Neflamapimod Development with New 50 mg Tablet and FDA Update gurufocus.com
Nasdaq, S&P 500, Dow Futures Rebound Ahead Of PPI Data Even As Iran Tensions Simmer: Why ORCL, CRWV, ADBE, BATL, MU, ADTX Are In Focus - Stocktwits
Nasdaq, S&P 500, Dow Futures Rebound Ahead Of PPI Data Even As Iran Tensions Simmer: Why ORCL, CRWV, ADBE, BATL, MU, ADTX Are In Focus Stocktwits
CervoMed advances higher-dose neflamapimod formulation By Investing.com - Investing.com Nigeria
CervoMed advances higher-dose neflamapimod formulation By Investing.com Investing.com Nigeria
FDA Lifts Neflamapimod Dosage Restriction, Boosting CervoMed (CR - gurufocus.com
FDA Lifts Neflamapimod Dosage Restriction, Boosting CervoMed (CR gurufocus.com
CervoMed Advances Neflamapimod Tablet and Dosing Strategy - TipRanks
CervoMed Advances Neflamapimod Tablet and Dosing Strategy TipRanks